查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542936

全球骨整合植入物市場 - 2024-2031

Global Osseointegration Implants Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年全球骨整合植入物市場達521萬美元，預估至2031年將達1,520萬美元，2024-2031年預測期間複合年成長率為15.6%

骨整合植入物是一種醫療設備，可在活骨和人造植入物表面之間建立直接連接，確保穩定性和耐用性。它們最初是為牙科應用而開發的，後來擴展到骨科和義肢，以確保關節置換和肢體義肢的安全。這項技術徹底改變了植體整合，提高了舒適度、功能性和長期成功，從而改善了各個領域的結果。

市場動態：

驅動程式和限制

設備進步的提高

骨整合可以透過微米和奈米尺度的表面修飾來改善。生物活性劑可以進一步提高骨整合潛力。目前使用的藥物有無機化合物、生長因子（BMP 和非 BMP）和抗再吸收藥物。因此，新一代植體的研究進展旨在積極支持骨整合處理。

此外，TSIII SOI植體是牙科植體領域的突破性進展，具有前所未有的凝血能力和優異的骨整合特性。這些生物相容性的最新成就改善了整個患者體驗並支持美觀和功能恢復。

與植入相關的高成本

骨整合植體市場面臨諸如高成本、手術程序、手術複雜性、專業培訓、監管障礙以及對長期成功和潛在併發症的擔憂等挑戰。這些因素使得低收入和中等收入地區的患者更難獲得這些技術，並阻礙了這些技術的廣泛採用。

此外，監管障礙和漫長的核准流程可能會延遲創新產品的市場進入。這些因素可能會影響患者和臨床醫生對採用先進解決方案的信心。

細分市場分析

全球骨整合植入物市場根據產品類型、材料類型、最終用戶和地區進行細分。

該產品類型細分市場的牙種植體約佔骨結合植體市場佔有率的41.3%

植牙產品類型細分市場佔比約41.3%。牙植體對於骨整合至關重要，骨整合是植體充當人造牙根的過程。隨著時間的推移，周圍的骨組織生長並與植入物表面融合，形成穩定的連結。這種骨整合使植體能夠牢固錨定，為牙冠、牙橋或假牙提供堅實的基礎。這種黏合的強度確保植體能夠承受咀嚼力並保持骨骼完整性，防止牙齒脫落後骨吸收。

例如，2024 年 2 月，牙科和脊椎市場的全球生命科學領導者 ZimVie Inc 宣佈在日本推出 TSX 植體。日本作為ZimVie在亞太地區最大、全球第五大的植牙市場，對ZimVie來說具有重要的戰略意義。 TSX 在日本的推出使該公司能夠與牙科植牙領域的優質市場領導者展開正面競爭。

市場地域佔有率

預計北美在整個預測期內將佔據總市場佔有率的 38.4% 左右

由於新產品的推出、 FDA 的批准以及與其他公司的擴張，北美在整個預測期內預計將佔據約 38.4% 的總市場佔有率。此外，成長可歸因於發達的醫療基礎設施、醫療保健支出的增加以及對微創手術的更高認知。

例如，2023 年 3 月，西維吉尼亞大學醫學中心成為該國首批提供 Integrum Osseo 截肢者復健錨定義肢 (OPRA(TM)) 植入系統用於治療下肢截肢的醫療中心之一。

此外，2023 年 7 月，Parkview 地區醫療中心和東北骨科在印第安納州啟動了一項骨整合計劃，利用 Integrum 的 OPRA 植體系統。這項創新計畫是該州首創，採用先進的骨錨式義肢技術來改善下肢截肢患者的生活品質。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 設備進步的提高
      • 骨科疾病盛行率上升
    • 限制
      • 與植入相關的高成本
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 專利分析
  • 大環境分析
  • SWOT分析
  • DMI 意見

第 6 章：依產品類型

  • 植牙
  • 膝關節植入物
  • 髖關節植入物
  • 脊椎植入物
  • 其他

第 7 章：依材料類型

  • 鈦植入物
  • 氧化鋯植體
  • 不銹鋼植入物
  • 陶瓷植入物
  • 其他

第 8 章：最終用戶

  • 醫院
  • 門診手術中心
  • 牙醫診所
  • 骨科診所
  • 其他

第 9 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Danaher Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Camlog
  • Osstem Implant
  • Medtronic
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Smith and Nephew Plc
  • Straumann AG Group
  • Integrum SE
  • ConMed Corporation (*LIST NOT EXHAUSTIVE)

第 12 章：附錄

簡介目錄
Product Code: MD984

Report Overview

Global Osseointegration Implants Market reached US$ 5.21 million in 2023 and is expected to reach US$ 15.20 million by 2031, growing at a CAGR of 15.6% during the forecast period 2024-2031

Osseointegration implants are medical devices that create a direct connection between living bone and an artificial implant's surface, ensuring stability and durability. Initially developed for dental applications, they have since expanded to orthopedics and prosthetics, securing joint replacements and limb prostheses. This technology has revolutionized implant integration, improving comfort, functionality, and long-term success, leading to improved outcomes in various fields.

Market Dynamics: Drivers & Restraints

Rise in advancements of devices

Osseointegration can be improved by surface modification on the micro and nanoscale. Bioactive agents can further improve the osseointegration potential. Used agents at the moment are e.g. inorganic compounds, growth factors (BMPs and non-BMPs), and antiresorptive drugs. The advancement in research on new implant generations therefore aims at actively supporting osseointegration processing.

Moreover, the TSIII SOI implant is a groundbreaking advancement in the field of dental implantology, boasting unprecedented blood coagulation capability and excellent osseointegration characteristics. These recent achievements in biocompatibility improve the entire patient experience and support aesthetic and functional restoration.

High cost associated with implants

The osseointegration implants market faces challenges such as high costs, surgical procedures, complexity of surgery, specialized training, regulatory hurdles, and concerns about long-term success and potential complications. These factors make them less accessible to patients in low- and middle-income regions and hinder the widespread adoption of these techniques.

Additionally, regulatory hurdles and lengthy approval processes can delay market entry for innovative products. These factors can affect patient and clinician confidence in adopting advanced solutions.

Market Segment Analysis

The global osseointegration implants market is segmented based on product type, material type, end-user, and region.

The dental implants from the product type segment accounted for approximately 41.3% of the osseointegration implants market share

The dental implants from the product type segment accounted for approximately 41.3%. Dental implants are vital for osseointegration, a process where the implant acts as an artificial tooth root. Over time, the surrounding bone tissue grows and integrates with the implant's surface, forming a stable connection. This osseointegration allows the implant to be firmly anchored, providing a solid foundation for dental crowns, bridges, or dentures. The strength of this bond ensures the implant can withstand chewing forces and maintain bone integrity, preventing bone resorption after tooth loss.

For instance, in February 2024, ZimVie Inc a global life sciences leader in the dental and spine markets, announced the launch of the TSX Implant in Japan. As ZimVie's largest dental implant market in APAC and the fifth largest market globally, Japan is of great strategic importance to ZimVie. The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to novel product launches, FDA approvals, and expansion with other companies. Also, growth can be attributed to developed healthcare infrastructure, greater expenditure on healthcare, and higher awareness about minimally invasive surgeries.

For instance, in March 2023, WVU Medicine became one of the first medical centers in the country to offer the Integrum Osseo anchored Prostheses for the Rehabilitation of Amputees (OPRA(TM)) Implant System for the treatment of lower extremity amputations.

Moreover, in July 2023, Parkview Regional Medical Center and Orthopedics North East launched an osseointegration program in Indiana, utilizing Integrum's OPRA Implant System. This innovative program, the first of its kind in the state, uses advanced bone-anchored prosthesis technology to improve the quality of life for individuals with lower extremity amputations.

Market Segmentation

By Product Type

  • Dental Implants
  • Knee Implants
  • Hip Implants
  • Spinal Implants
  • Others

By Material Type

  • Titanium Implants
  • Zirconia Implants
  • Stainless Steel Implants
  • Ceramic Implants
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Dental Clinics
  • Orthopedic Clinics
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Market Competitive Landscape

The major global players in the market include Danaher Corporation, Camlog, Osstem Implant, Medtronic, Stryker Corporation, Zimmer Biomet Holdings, Smith and Nephew Plc, Straumann AG Group, Integrum SE, and ConMed Corporation among others.

Key Developments

  • In September 2023, Neoss Group, a dental implant solutions pioneer, partnered with Osstell AB to introduce NeoTell, an affordable, rapid, and precise device designed to measure implant stability. NeoTell equips clinicians with the tools to assess implant stability quickly and accurately, improving patient outcomes and simplifying digital workflow.
  • In January 2023, Specialists at the Osstem's Bone Science Research Institute devoted themselves to developing ways to regenerate bone and soft tissue by applying a state-of-the-art molecular and cell biology technique to tissue response and taking a physio-chemical approach to implant and bio-implant materials.

Why Purchase the Report?

  • To visualize the global osseointegration implants market segmentation based on product type, material type, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the osseointegration implants market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in Excel and consists of key products of all the major players.

The global osseointegration implants market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

¬¬¬¬

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in advancements of devices
      • 4.1.1.2. Rise in the prevalence of orthopedic disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High cost associated with implants
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis
  • 5.6. PESTLE Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Dental Implants *
    • 6.2.1. Introduction
  • 6.3. Knee Implants
  • 6.4. Hip Implants
  • 6.5. Spinal Implants
  • 6.6. Others

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 7.2. Market Attractiveness Index, By Material Type
  • 7.3. Titanium Implants*
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.4. Zirconia Implants
  • 7.5. Stainless Steel Implants
  • 7.6. Ceramic Implants
  • 7.7. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Dental Clinics
  • 8.5. Orthopedic Clinics
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Danaher Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Camlog
  • 11.3. Osstem Implant
  • 11.4. Medtronic
  • 11.5. Stryker Corporation
  • 11.6. Zimmer Biomet Holdings
  • 11.7. Smith and Nephew Plc
  • 11.8. Straumann AG Group
  • 11.9. Integrum SE
  • 11.10. ConMed Corporation (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us